Pacific Biosciences Of California (PACB) EBITDA Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Pacific Biosciences Of California (PACB) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.64 Bn | 221.57 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 144.47 Bn | 140.12 Bn | 3.61 Bn | -168.00 |
| 3 | Agilent Technologies | 40.90 Bn | 39.15 Bn | 1.04 Bn | 1,569.00 |
| 4 | Illumina | 30.90 Bn | 29.73 Bn | 770.00 Mn | 2,862.00 |
| 5 | Revvity | 13.85 Bn | 12.82 Bn | 416.87 Mn | 123.00 |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | -825.00 |
| 7 | Bio-Rad Laboratories | 10.12 Bn | 8.50 Bn | 345.80 Mn | -201.00 |
| 8 | Repligen | 9.28 Bn | 8.27 Bn | 110.04 Mn | -527.00 |
| 9 | 10x Genomics | 8.70 Bn | 8.14 Bn | 112.50 Mn | 3,021.00 |
| 10 | Pacific Biosciences Of California | 397.64 Mn | 160.77 Mn | 12.64 Mn | 3,946.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,946.00 |
| Mar 31, 2026 | 21,094.00 |
| Dec 31, 2025 | 22,288.00 |
| Sep 30, 2025 | 12,895.00 |
| Jun 30, 2025 | 7,898.00 |
| Mar 31, 2025 | -91,384.00 |
| Dec 31, 2024 | -20,327.00 |
| Jun 30, 2024 | -35,582.00 |
| Mar 31, 2024 | -8,504.00 |
| Dec 31, 2023 | -5,650.00 |
| Sep 30, 2023 | -1,622.00 |
| Jun 30, 2023 | -1,012.00 |
| Mar 31, 2023 | -1,780.00 |
| Dec 31, 2022 | -24,485.00 |
| Sep 30, 2022 | -9,540.00 |
| Jun 30, 2022 | -8,607.00 |
| Mar 31, 2022 | -4,339.00 |
| Dec 31, 2021 | -2,273.00 |
| Jun 30, 2021 | -2,197.00 |
| Mar 31, 2021 | 744.00 |